Trial Profile
A Phase 2 Study of ABT-751 in Subjects With Refractory Colorectal Carcinoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Jan 2008
Price :
$35
*
At a glance
- Drugs ABT 751 (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 28 Nov 2007 Status change from in progress to completed.
- 20 Sep 2005 New trial record.